Class Action Lawsuit Filed Against Picard Medical, Inc.

Written by Emily J. Thompson, Senior Investment Analyst

Source: Globenewswire

Updated: Feb 23 2026

0mins

PMI+2.59%

Should l Buy PMI?

Source: Globenewswire

Class Action Initiation: A class action lawsuit has been filed against Picard Medical for allegedly issuing false statements between September 2 and October 31, 2025, with investors having until April 3, 2026, to seek lead plaintiff status, highlighting serious concerns over the company's transparency and integrity.
False Promotion Allegations: The complaint alleges that Picard was involved in a fraudulent stock promotion scheme utilizing social media misinformation and impersonation of financial professionals, which artificially inflated stock prices and could lead to significant financial losses for investors.
Insider Trading Investigation: The lawsuit also claims that insiders or affiliates used offshore accounts to facilitate coordinated share dumping, exacerbating stock price volatility and indicating potential flaws in the company's governance structure.
Law Firm Credentials: Wolf Haldenstein Adler Freeman & Herz LLP, founded in 1888, boasts over 125 years of experience in securities litigation, dedicated to pursuing justice for investors harmed by misrepresented statements, underscoring its authority in the legal field.

Trade with 70% Backtested Accuracy

Stop guessing "Should I Buy PMI?" and start using high-conviction signals backed by rigorous historical data.

Analyst Views on PMI

About PMI

Picard Medical, Inc. is a holding company that owns a 100% interest in SynCardia Systems, LLC (SynCardia). SynCardia is a medical technology company that manufactures and sells the only United States Food and Drug Administration (FDA) and Health Canada-approved implantable total artificial heart (SynCardia TAH). The SynCardia TAH is a biventricular replacement device that consists of the SynCardia TAH implant, an external pneumatic driver that delivers precisely calibrated pulses of air to drive the implant, and drivelines that connect the driver to the implant. The SynCardia TAH implant is a system that consists of two independent artificial ventricles which are powered by an external pneumatic driver. Each artificial ventricle is made of a semi-rigid polyurethane housing and a rigid polyurethane base, with a four-layer flexible polyurethane diaphragm separating the blood chamber from the air chamber.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Class Action Notice for Picard Medical Securities Purchasers

53 minutes agoGlobenewswire

Class Action Deadline: The lead plaintiff deadline for the Picard Medical securities class action is April 13, 2026, requiring investors to apply by this date to represent other investors in the litigation.
Lawsuit Background: The lawsuit alleges that Picard Medical made materially false and misleading statements from September 2 to October 31, 2025, failing to disclose significant adverse facts about its business and securities trading, resulting in investor losses.
Legal Counsel Selection: Investors are encouraged to choose qualified legal counsel with a proven track record, avoiding firms that merely act as intermediaries, to ensure effective legal support in the class action.
Historical Performance: Rosen Law Firm has recovered over $438 million for investors in 2019 alone and achieved the largest securities class action settlement against a Chinese company in 2017, demonstrating its strong capabilities in securities class actions.

Multiple Companies Face Class Action Lawsuits

2 hours agoGlobenewswire

Richtech Robotics Lawsuit: Richtech Robotics Inc. is facing allegations for failing to disclose its non-existent collaboration with Microsoft during the class period from January 27 to January 29, 2026, misleading investors about the company's prospects, with a lead plaintiff motion deadline set for April 3, 2026.
Picard Medical Allegations: Picard Medical, Inc. is accused of being involved in a fraudulent stock promotion scheme from September 2 to October 31, 2025, failing to disclose critical information that undermined investor confidence, with the same lead plaintiff motion deadline of April 3, 2026.
Plug Power Legal Issues: Plug Power, Inc. is under scrutiny for allegedly overstating the availability of funds related to a DOE loan during the period from January 17 to November 13, 2025, misleading investors about future projects, with a lead plaintiff motion deadline of April 3, 2026.
Legal Consultation Reminder: The Law Offices of Frank R. Cruz encourage affected investors to reach out for legal advice regarding their rights, providing contact details including phone and email for inquiries.

Picard Medical Investors Advised on Class Action Lawsuit

1 day agoGlobenewswire

Class Action Notice: The Portnoy Law Firm advises Picard Medical investors of a class action lawsuit for those who purchased securities between September 5 and October 31, 2025, with a deadline of April 3, 2026, for filing a lead plaintiff motion to protect their legal rights.
Stock Price Crash: The complaint reveals that Picard's stock price plummeted 70% on October 24, 2025, from $13.30 to $3.99 per share, and has since continued to decline to approximately $2.00, indicating a severe loss of market confidence in the company.
Fraud Allegations: The lawsuit alleges that Picard failed to disclose its involvement in a fraudulent stock promotion scheme utilizing social media misinformation, and insiders used offshore accounts to facilitate coordinated share dumping, significantly harming investor interests.
Legal Support: The Portnoy Law Firm offers complimentary case evaluations to assist investors in recovering losses due to corporate wrongdoing, with its founding partner having successfully recovered over $5.5 billion for aggrieved investors, showcasing its strong legal expertise.

Class Action Lawsuit Reminder Against Picard Medical, Inc.

1 day agoGlobenewswire

Class Action Notification: The Schall Law Firm reminds investors of a class action lawsuit against Picard Medical, Inc. (NYSE American:PMI) for violations of securities laws during the period from September 2, 2025, to October 31, 2025, with a deadline to contact the firm by April 3, 2026, to participate.
False Statements Allegation: The complaint alleges that Picard Medical made false and misleading statements during the class period, resulting in a manipulation scheme that fraudulently inflated its share price, with insiders selling shares at these artificially high prices, causing investor losses.
Loss Recovery Opportunity: Investors who purchased the company's securities during the class period and suffered losses are encouraged to join the lawsuit to seek compensation, with the Schall Law Firm specializing in securities class actions and offering free consultations.
Legal Process Status: The class action has not yet been certified, meaning investors are not represented by an attorney until certification occurs, and those who choose not to act will remain absent class members, potentially affecting their rights to recover losses.